SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-18-000063
Filing Date
2018-05-09
Accepted
2018-05-09 17:08:22
Documents
51
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-3311810q.htm 10-Q 850599
2 EXHIBIT 10.1 lgnd-ctrxretrophinredacted.htm EX-10.1 31134
3 EXHIBIT 10.2 finalligand-roivantgralice.htm EX-10.2 279457
4 EXHIBIT 31.1 lgnd_33118exhibit311.htm EX-31.1 16488
5 EXHIBIT 31.2 lgnd_33118exhibit312.htm EX-31.2 16396
6 EXHIBIT 32.1 lgnd_33118exhibit321.htm EX-32.1 15618
  Complete submission text file 0000886163-18-000063.txt   5642864

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lgnd-20180331.xml EX-101.INS 1283694
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20180331.xsd EX-101.SCH 33288
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20180331_cal.xml EX-101.CAL 71482
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20180331_def.xml EX-101.DEF 179746
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20180331_lab.xml EX-101.LAB 538472
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20180331_pre.xml EX-101.PRE 300450
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 18819336
SIC: 2834 Pharmaceutical Preparations